business
Elliott Builds Stake in Life-Science Firm Bio-Rad, WSJ Says
Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories to boost the firm’s underperfoming stock price, the Wall Street Journal reported, citing people familiar with the matter.
Read full story on Bloomberg Markets → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop